BEAM
Price
$16.70
Change
-$0.07 (-0.42%)
Updated
Jun 23, 04:59 PM (EDT)
Capitalization
1.69B
50 days until earnings call
EDIT
Price
$2.11
Change
-$0.11 (-4.95%)
Updated
Jun 23, 04:59 PM (EDT)
Capitalization
185.84M
37 days until earnings call
Interact to see
Advertisement

BEAM vs EDIT

Header iconBEAM vs EDIT Comparison
Open Charts BEAM vs EDITBanner chart's image
Beam Therapeutics
Price$16.70
Change-$0.07 (-0.42%)
Volume$21.22K
Capitalization1.69B
Editas Medicine
Price$2.11
Change-$0.11 (-4.95%)
Volume$17.29K
Capitalization185.84M
BEAM vs EDIT Comparison Chart in %
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EDIT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEAM vs. EDIT commentary
Jun 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Hold and EDIT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 23, 2025
Stock price -- (BEAM: $16.76 vs. EDIT: $2.22)
Brand notoriety: BEAM and EDIT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 118% vs. EDIT: 152%
Market capitalization -- BEAM: $1.69B vs. EDIT: $185.84M
BEAM [@Biotechnology] is valued at $1.69B. EDIT’s [@Biotechnology] market capitalization is $185.84M. The market cap for tickers in the [@Biotechnology] industry ranges from $326.23B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 1 FA rating(s) are green whileEDIT’s FA Score has 0 green FA rating(s).

  • BEAM’s FA Score: 1 green, 4 red.
  • EDIT’s FA Score: 0 green, 5 red.
According to our system of comparison, EDIT is a better buy in the long-term than BEAM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 2 TA indicator(s) are bullish while EDIT’s TA Score has 5 bullish TA indicator(s).

  • BEAM’s TA Score: 2 bullish, 6 bearish.
  • EDIT’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, EDIT is a better buy in the short-term than BEAM.

Price Growth

BEAM (@Biotechnology) experienced а -1.76% price change this week, while EDIT (@Biotechnology) price change was +12.69% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.37%. For the same industry, the average monthly price growth was +28.11%, and the average quarterly price growth was +12.64%.

Reported Earning Dates

BEAM is expected to report earnings on Aug 12, 2025.

EDIT is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Biotechnology (-2.37% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($1.69B) has a higher market cap than EDIT($186M). EDIT YTD gains are higher at: 74.803 vs. BEAM (-32.419). EDIT has higher annual earnings (EBITDA): -244.52M vs. BEAM (-399.03M). BEAM has more cash in the bank: 1.22B vs. EDIT (221M). EDIT has less debt than BEAM: EDIT (31.1M) vs BEAM (158M). BEAM has higher revenues than EDIT: BEAM (63.6M) vs EDIT (35.8M).
BEAMEDITBEAM / EDIT
Capitalization1.69B186M906%
EBITDA-399.03M-244.52M163%
Gain YTD-32.41974.803-43%
P/E RatioN/AN/A-
Revenue63.6M35.8M178%
Total Cash1.22B221M552%
Total Debt158M31.1M508%
FUNDAMENTALS RATINGS
EDIT: Fundamental Ratings
EDIT
OUTLOOK RATING
1..100
21
VALUATION
overvalued / fair valued / undervalued
1..100
39
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMEDIT
RSI
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
85%
Bearish Trend 4 days ago
89%
Momentum
ODDS (%)
Bearish Trend 4 days ago
87%
Bullish Trend 4 days ago
76%
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
84%
Bullish Trend 4 days ago
78%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
84%
Bullish Trend 4 days ago
77%
Advances
ODDS (%)
Bullish Trend 6 days ago
78%
Bullish Trend 14 days ago
76%
Declines
ODDS (%)
Bearish Trend 8 days ago
85%
Bearish Trend 25 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
82%
Bearish Trend 4 days ago
84%
Aroon
ODDS (%)
Bearish Trend 4 days ago
89%
Bullish Trend 4 days ago
75%
View a ticker or compare two or three
Interact to see
Advertisement
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EDIT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ECSTX25.990.04
+0.15%
Eaton Vance Large-Cap Value C
TMAPX52.720.04
+0.08%
Touchstone Mid Cap A
ORSAX14.00-0.02
-0.14%
North Square Dynamic Sm Cp A
VYSAX14.05-0.05
-0.35%
Voya Small Company I
TISDX11.59-0.12
-1.02%
Transamerica Intl Sust Eq A